The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer
Open accessAbstract
Activatable cell penetrating peptides (ACPPs) are novel in vivo targeting agents comprised of a polycationic cell penetrating peptide (CPP) connected via a cleavable linker to a neutralizing polyanion (). Adsorption and uptake into cells are inhibited until the linker is proteolyzed. An ACPP cleavable by matrix metalloproteinase-2 (MMP-2) in vitro was the first one demonstrated to work in a tumor model in vivo, but only HT-1080 xenografts and resected human squamous cell carcinomas were tested. Generality to other cancer types, in vivo selectivity of ACPPs for MMPs, and spatial resolution require further characterization. We now show that ACPPs can target many xenograft tumor models from different cancer sites, as well as a thoroughly studied transgenic model of spontaneous breast cancer (mouse mammary tumor virus promoter driving polyoma middle T antigen, MMTV-PyMT). Pharmacological inhibitors and genetic knockouts indicate that current ACPPs are selective for MMP-2 and MMP-9 in the above in vivo models. In accord with the known local distribution of MMP activity, accumulation is strongest at the tumor-stromal interface in primary tumors and associated metastases, indicating better spatial resolution (<50 mum) than other currently available MMP-cleavable probes. We also find that background uptake of ACPPs into normal tissues such as cartilage can be decreased by appending inert macromolecules of 30-50 KDa to the polyanionic inhibitory domain. Our results validate an approach that should generally deliver imaging agents and chemotherapeutics to sites of invasion, tumor-promoting inflammation, and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Weissleder, R., Tung, C.-H., Mahmood, U., & Bogdanov, A. (1999) · Nature Biotechnology · doi:10.1038/7933 · Cited by 1,591
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
Self-citationDucharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L. E., Schoen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808
In vivo molecular target assessment of matrix metalloproteinase inhibition
Bremer, C., Tung, C.-H., & Weissleder, R. (2001) · Nature Medicine · doi:10.1038/89126 · Cited by 726
Near-Infrared Optical Imaging of Protease Activity for Tumor Detection
Mahmood, U., Tung, C.-H., Bogdanov, A., & Weissleder, R. (1999) · Radiology · doi:10.1148/radiology.213.3.r99dc14866 · Cited by 301
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
Turpeenniemi-Hujanen, T. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.014 · Cited by 289
Optical Imaging of Matrix Metalloproteinase–2 Activity in Tumors: Feasibility Study in a Mouse Model
Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., & Tung, C.-H. (2001) · Radiology · doi:10.1148/radiol.2212010368 · Cited by 255
Recent advances in MMP inhibitor design
Fisher, J. F., & Mobashery, S. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7894-9 · Cited by 215
Aguilera, T. A., Olson, E. S., Timmers, M. M., Jiang, T., & Tsien, R. Y. (2009) · Integrative Biology · doi:10.1039/b904878b · Cited by 198
Self-citationTransport of solutes through cartilage: permeability to large molecules.
Maroudas, A. (1976) · PubMed · Cited by 194
Määttä, M., Soini, Y., Liakka, A., & Autio‐Harmainen, H. (2000) · PubMed · Cited by 178
Oliver McINTYRE, J., FINGLETON, B., WELLS, K. S., PISTON, D. W., LYNCH, C. C., GAUTAM, S., & MATRISIAN, L. M. (2004) · Biochemical Journal · doi:10.1042/bj20030582 · Cited by 160
Persistent use of “false” cell lines
Lacroix, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23233 · Cited by 151
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
Trudel, D., Fradet, Y., Meyer, F., Harel, F., & Têtu, B. (2003) · PubMed · Cited by 133
Frederiks, W. M., & Mook, O. R. F. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4r6251.2004 · Cited by 123
Protease‐Triggered Unveiling of Bioactive Nanoparticles
Harris, T. J., von Maltzahn, G., Lord, M. E., Park, J., Agrawal, A., Min, D., Sailor, M. J., & Bhatia, S. N. (2008) · Small · doi:10.1002/smll.200701319 · Cited by 117
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Chabottaux, V., & Noël, A. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9113-7 · Cited by 114
Protease-Modulated Cellular Uptake of Quantum Dots
Zhang, Y., So, M. K., & Rao, J. (2006) · Nano Letters · doi:10.1021/nl0611586 · Cited by 110
Mannello, F. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159608 · Cited by 93
Kleifeld, O., Kotra, L. P., Gervasi, D. C., Brown, S., Bernardo, M. M., Fridman, R. A., Mobashery, S., & Sagi, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011604200 · Cited by 74
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer
Leinonen, T., Pirinen, R. T., Böhm, J., Johansson, R. T., Ropponen, K. M., & Kosma, V. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.11.002 · Cited by 67
Lebel, R., ̧bska, B. J., Therriault, H., Cournoyer, M., McIntyre, J. O., Escher, E., Neugebauer, W. A., Paquette, B., & Lepage, M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21741 · Cited by 54
Pedersen, T. X., Pennington, C. J., Almholt, K., Christensen, I. J., Nielsen, B. S., Edwards, D. R., Rømer, J., Danø, K., & Johnsen, M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi065 · Cited by 45
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,147
Cell-Penetrating Peptides: Design, Synthesis, and Applications
Copolovici, D. M., Langel, K., Eriste, E., & Langel, Ü. (2014) · ACS Nano · doi:10.1021/nn4057269 · Cited by 963
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Metadata
- Authors
- Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., Gross, L. A., & Tsien, R. Y.
- Venue
- Integrative Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-11
- Volume
- 1
- Issue
- 5-6
- Pages
- 382-393
- ISSN
- 1757-9694 (ISSN-L)
- 1757-9708
- OpenAlex
- W1975148998
- Cited by
- 263
- References
- 26
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.